An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer
AM Sawka, JD Brierley, RW Tsang, L Thabane… - … and metabolism clinics …, 2008 - Elsevier
Radioactive iodine remnant ablation (RRA) is used to destroy residual normal thyroid tissue
after complete gross surgical resection of papillary or follicular thyroid cancer. The article …
after complete gross surgical resection of papillary or follicular thyroid cancer. The article …
A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer
AM Sawka, K Thephamongkhol… - The Journal of …, 2004 - academic.oup.com
Radioactive iodine remnant ablation destroys residual thyroid tissue after surgical resection
of papillary or follicular thyroid cancer. We systematically reviewed 1543 English references …
of papillary or follicular thyroid cancer. We systematically reviewed 1543 English references …
Radioiodine ablation following thyroidectomy for differentiated thyroid cancer: literature review of utility, dose, and toxicity
NS Andresen, JM Buatti, HH Tewfik… - European thyroid …, 2017 - etj.bioscientifica.com
Management recommendations for differentiated thyroid cancer are evolving. Total
thyroidectomy is the backbone of curative-intent therapy, with radioiodine ablation (RAI) of …
thyroidectomy is the backbone of curative-intent therapy, with radioiodine ablation (RAI) of …
Recombinant human thyroid stimulating hormone–assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence
J Hugo, E Robenshtok, R Grewal, S Larson, RM Tuttle - Thyroid, 2012 - liebertpub.com
Background: Multiple studies have demonstrated successful radioactive iodine remnant
ablation (RRA) following preparation with recombinant human thyroid stimulating hormone …
ablation (RRA) following preparation with recombinant human thyroid stimulating hormone …
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature
L Lamartina, C Durante, S Filetti… - The Journal of Clinical …, 2015 - academic.oup.com
Background: Radioiodine remnant ablation (RRA) has traditionally been one of the
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …
Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease …
F Vaisman, A Shaha, S Fish… - Clinical …, 2011 - Wiley Online Library
Objective To describe the risk of structural disease recurrence in a cohort of patients with
differentiated thyroid cancer selected for treatment with either thyroid lobectomy or total …
differentiated thyroid cancer selected for treatment with either thyroid lobectomy or total …
Low-or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis
W Cheng, C Ma, H Fu, J Li, S Chen… - The Journal of …, 2013 - academic.oup.com
Context: There is uncertainty over the dose of 131I required for thyroid remnant ablation.
Most previous studies have been inadequately powered to establish the best fixed dose of …
Most previous studies have been inadequately powered to establish the best fixed dose of …
Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial
Objectives Radioiodine ablation of thyroid tissue remains the cornerstone of treatment for
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose …
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose …
The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008
Background: Radioactive iodine (RAI) remnant ablation has been used to eliminate normal
thyroid tissue and may also facilitate monitoring for persistent or recurrent thyroid carcinoma …
thyroid tissue and may also facilitate monitoring for persistent or recurrent thyroid carcinoma …
Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low …
J Lee, MJ Yun, KH Nam, WY Chung, EY Soh, CS Park - Thyroid, 2010 - liebertpub.com
Background: Few reports have examined the use of recombinant human thyroid-stimulating
hormone (rhTSH) for ablation of postsurgical thyroid remnants after low-dose radioactive …
hormone (rhTSH) for ablation of postsurgical thyroid remnants after low-dose radioactive …
相关搜索
- thyroid cancer remnant ablation
- thyroid cancer radioactive iodine
- systematic analysis radioactive iodine
- thyroid cancer systematic analysis
- thyroid cancer metaanalysis of the effectiveness
- thyroid cancer low risk
- thyroid tissue postoperative ablation
- 131i activity remnant ablation
- thyroid cancer 131i activity
- thyroid cancer radioiodine ablation
- thyroid carcinoma postoperative ablation